Beijing Tiantan Hospital

BEIJING TIANTAN HOSPITAL

Established in 1956, Beijing Tian Tan Hospital, Capital Medical University, is a prestigious general hospital that encompasses medical treatment, scientific research, medical education, and disease prevention. It is particularly known for its expertise in neuroscience, with a focus on neurosurgery. With diligent work and rigorous efforts spanning over fifty years, the hospital has successfully attained significant advancements and risen to become one of the leading medical institutions in China, renowned for its cutting-edge medical technology and esteemed reputation.

The hospital currently has more than 30 clinical departments and 11 auxiliary departments, all equipped with state-of-the-art medical technology. Additionally, the number of patient visits has consistently risen, reaching over 1,000,000 outpatient visits and 30,000 inpatient admissions per year.

The Neurosurgery Center at Tiantan Hospital, established by Zhongcheng Wang, an academician of the Chinese Academy of Sciences, is widely acknowledged as the largest neurosurgical facility globally. Similarly, the Beijing Neurosurgical Institute is renowned as the foremost research institute in the field of clinical medicine.

The hospital houses several organizations, including the Fifth Institutional Faculty of Clinical Medicine affiliated with the Capital Medical University, the WHO Collaborating Center in China for Neural Science and Training, the Beijing Neurosurgical College, the National Cerebrovascular Disease Prevention Research Office, the Beijing Cerebrovascular Disease Prevention Research Office, and the editorial offices of the Chinese Journal of Neurosurgery and Chinese Journal of Stroke.

Tiantan Hospital boasts a team of 395 specialists, which includes renowned professors in the field of neurosurgery such as Zhongcheng Wang (an academician of the Chinese Academy of Sciences and recipient of the State Supreme Science and Technology Award), Yadu Zhao, Shiqi Luo, and Jizong Zhao.

Additionally, the hospital also houses senior experts in various other subjects. There are a total of 27 mentors with doctorate degrees and 79 mentors with master’s degrees. Neurosurgery, neurology, and neuroradiology are designated as important national specialties. The hospital undertook numerous state-level research initiatives, while simultaneously receiving multiple National Science and Technology Progress Awards for its clinical research programs focused on neurology.

The municipal government has accepted the hospital relocation proposal, taking into consideration aspects such as the hospital’s development demands, health planning, and the protection of the World Cultural Heritage. The new hospital is situated on the South Fourth Ring Road in the Fengtai District, in close proximity to the Huaxiang Bridge. The land allocation for building purposes exceeds 300 acres, encompassing a total development area of approximately 350,000 square meters.

The financial fund amounts to more than 30 billion yuan, which is roughly four times the size of the former hospital’s endowment. The construction of the new hospital will be finished prior to 2015. The new hospital will have a total of 1650 beds, including 200 intensive care beds and 63 full laminar flow operating rooms. It will also be equipped with various departments and state-of-the-art technology.

The removal and reestablishment of Tiantan Hospital are significant catalysts for its development. The hospital remains committed to the philosophy of “high starting-point, high level, and high quality” in order to meet the requirements of the future. Tiantan Hospital strengthens its position as a leading center for neurosurgery and neurology. It also promotes the development of integrated subjects and aims to build a diverse and highly skilled team to achieve Tiantan Person’s ultimate goal.

August 23, 1956, saw the founding of the Capital Medical University’s Beijing Tiantan Hospital. It combines clinical practice, research, and training to become one of Asia’s premier institutions for neuroscience. The National Clinical Medical Research Center for Neurological Diseases, the National Medical Quality Control Center for Neurological Diseases, the National Practice Skills Examination Base for Physician Qualification Examination, the WHO Neuroscience Training Cooperation Center, the Beijing Neurosurgery Institute, the National Cerebrovascular Disease Prevention and Control Office, and the Fifth Clinical School of the Capital Medical University are all housed at the Beijing Tiantan Hospital.

Over the course of its 67-year existence, the hospital has nurtured several accomplished neuroscientists, including esteemed academicians Wang Yongcheng and Zhao Jizong, as well as Professor Dai Jianping and Professor Wang Yongjun. Currently, the hospital houses three National Key Disciplines and five National Clinical Key Specialties, such as neurosurgery and neurology. These specialties have regularly held the top place in the Science and Technology Evaluation Metrics (STEM) for Chinese hospitals since 2017.

The hospital accommodates one member of the Chinese Academy of Sciences, two scholars from Beijing, one participant in the young Changjiang scholars program of the Ministry of Education, three participants in the Ten Thousand Talents Program, and one participant from the National Hundred Million Talents Program, among others.

It has received the prestigious National Science and Technology Progress Award, including one first prize and four second prizes. The institution has received approval for 15 doctorate programs and 25 master’s programs. It has a total of 70 doctoral supervisors and 142 master’s supervisors.

The Beijing Tiantan Hospital Neurosurgery Center (BTHNC) is widely recognized as the preeminent neurosurgery center in China. Dr. Wang Chungcheng, a prominent figure in the field of neurosurgery in China, established Beijing Tiantan Hospital in the early 1980s. The main objective of this endeavor was to create the Department of Neurosurgery. Since that time, BTHNC has grown to become the most extensive neurosurgery facility in China.

Collaboratively, clinicians and scientists from the departments of neurosurgery, neuroradiology, neuropathology, and the Brain Research Institute are dedicated to uncovering and finding remedies for disorders affecting the central nervous system. Additionally, it serves as the primary hub for neurosurgical training in China.

The Division of Neurosurgery is dedicated to maintaining a high standard of leadership in the various fields of neurosurgery, offering a comprehensive spectrum of specialized services for both adult and pediatric patients. Brain tumors (such as gliomas, meningiomas, pituitary adenomas, and tumors in the brainstem and skull base), cerebral vascular diseases, pediatric neurosurgery, stereotactic and functional neurosurgery, epilepsy surgery, spinal tumor surgery, and brain injury are just some of the areas where neurosurgery centers have been set up to focus on.

The annual incidence of brain surgery has shown steady and constant growth, surpassing 7,000 cases since 2005. The yearly count of visits to the outpatient clinic exceeds 70,000. The faculty comprises 45 senior academics who are employed full-time and specialize in all aspects of neurosurgery clinical practice and basic research.

The hospital offers a wide range of specialties, including neurology, neurosurgery, oncology, cardiology, orthopedics, general surgery, pediatrics, and emergency medicine.

The development of the new Beijing Tiantian Hospital complex commenced in December 2013. Following a comprehensive trial in October 2018, the new campus commenced official operations on January 30, 2019. This relocation marked the first instance of a major tertiary hospital in Beijing being fully moved since the establishment of the country.

The new hospital is situated at No.119 South Fourth Ring West Road, Fengtai District. It spans an expansive area of 181,581 square meters, with a total construction area of 352,294 square meters. The facility is partitioned into three distinct functional divisions dedicated to medical treatment, administration, research, cadre health care, and education. The hospital houses a total of 67 clinical departments and eight medical technology departments. The facility has a total of 1,650 beds and employs a staff of 3,210 individuals.

Beijing Tiantan Neurosurgery Hospital is located at:

Address:
No. 119, Nan Sihuan Xilu, Fengtai District, Beijing, China.

How do I reach Beijing Tiantan Hospital?

1. By subway:
– Line 10: Take Line 10 to Fengtai Science Park Station. From there, you can take a taxi or a bus for a short distance to the hospital.
– Line 4: Get off at Beijing South Railway Station, then take a taxi or bus to the hospital.

2. By Bus:
– Bus Route 646 or 957: These buses stop near the hospital. Get off at the Tiantan Hospital Station.

3. By Taxi or Car:
– You can take a taxi or drive directly to the hospital. The location is well-known, so most drivers will be familiar with it.
– Use navigation apps like Baidu Maps or Google Maps (if accessible) to get precise directions.

4. From Beijing Capital International Airport:
– Take the Airport Express to Sanyuanqiao Station, then transfer to Line 10 and follow the subway directions above.
– Alternatively, you can take a taxi directly from the airport.

5. From Beijing Railway Station:
– Take Subway Line 2 to Xuanwumen Station, then transfer to Line 4 and follow the directions above.

Department of Neurosurgery at Beijing Tiantan Hospital
Capital University of Medical Sciences,
6 Tiantan Xili,

Chongwen District,

Beijing,
100050, People’s Republic of China

DIVISIONS OF NEUROSURGERY BRAINSTEM AND SKULLBASE TUMOR SUBDIVISION

Some brainstem tumors that were thought to be impossible to operate on have been successfully treated through surgery. These include cavernous malformations, hemangioblastomas, ependymomas, and ganglial gliomas. Published papers have documented hundreds of cases. The result of skull base cancer has significantly improved because of the increasing understanding of skull base tumor microanatomy and physiology, the use of intraoperative electrophysiological monitoring, and enhanced interdisciplinary collaboration.

The rate of maintaining the anatomical integrity of the facial nerve in gigantic acoustic neuromas has reached 98%, while the rate of completely removing the tumor is 93%. Every year, numerous meningiomas that invade the cavernous sinus, medial sphenoid ridge, clivus, post petrous, and foramen magnum are successfully treated with surgery. Positive outcomes are achieved in the treatment of certain skull base tumors, such as trigeminal neuromas, chordomas, and chondrosarcomas.

CEREBRAL VASCULAR DISEASES SUBDIVISION

This is the largest cardiovascular disease surgical center in China. Every year, about 300 instances of aneurysms and AVMs are treated with surgical clipping or resection, resulting in minimal complications and a mortality rate of less than 1.5%. Surgical intervention is used to treat Moya Moya disease, cavernous malformations, and stenosis of the internal carotid artery.

Vascular surgeons collaborate with neuroendovascular specialists to manage complex instances of aneurysms and arteriovenous malformations (AVMs), consistently prioritizing the patient’s best interest.

PEDIATRIC NEUROSURGERY SUBDIVISION

China has a limited number of neurosurgery sections dedicated to children. Every year, a total of 600 to 700 surgeries are conducted to remove various forms of brain and spinal tumors in children. In cases of craniopharyngioma, a significant number of patients undergo complete removal of the tumor, resulting in a positive long-term prognosis for the majority of them.

The utilization of both chemotherapy and radiotherapy following surgery for medulloblastomas results in a 5-year survival rate of 68%. More than 500 patients with intra-third ventricle tumors (craniopharyngiomas, teratomas, and gliomas in the anterior, middle,, or posterior regions) have undergone surgeries using the transcallosal-transfornixial approach.

These surgeries have resulted in excellent tumor resection outcomes and improved postoperative quality of life. The concurrent use of radiation and chemotherapy yields exceptional tumor control in both the short-term and long-term management of germinomas.

SUPRATENTORIAL TUMOR SUBDIVSION

Provides surgical treatment of meningiomas, gliomas, craniopharyngiomas, and other brain tumors.

GLIOMA TREATMENT SUBDIVISION

Comprehensive treatments are employed in the treatment of gliomas. Surgery, radiotherapy, chemotherapy, and immunotherapy are carried out for select patients. Although the treatment of malignant tumors, such as multiform glioblastomas, has undergone some advancement, it still poses a big challenge. Yearly, more than 700 patients receive treatment in this division.

PITUITARY ADENOMA TREATMENT SUBDIVISION

Annually, more than 500 patients undergo surgical resection and more than 5,000 visit the outpatient clinic. Individualized plans, including surgery, chemotherapy, and radiotherapy, are offered according to the tumor subtype and the patients’ needs.

FUNCTIONAL AND EPILEPSY SUBDIVISION

Surgery to treat movement disorders such as Parkinson’s disease and epilepsy have been conducted for more than 20 years. Currently, deep brain stimulators are implanted mono-laterally or bilaterally in tens of thousands of cases annually. Hundreds of cases of refractory epilepsy are cured through surgical approaches.

NEUROENDOSCOPY SUBDIVISION

Neuroendoscopy is used widely in the resection of pituitary adenomas, suprasellar and intraventricular cysts, and hydrocephalus treatment. More than 1500 cases have received this minimally invasive service in the past ten years.

BRAIN INJURY SUBDIVISION

Yearly, 700-900 brain injury cases, oftentimes severe, are transferred to this unit. The use of hypothermia, intracranial monitoring, and many other facilities are employed to rescue patients. Mortality and severe morbidity have dropped to a reasonable level. Computer-assisted 3-dimensionally-shaped titanium-alloy plates that fix skull defects lead to some extent to cosmetic symmetry and neurological improvement.

SPINAL TUMOR SUBDIVISION

Operations to remove intramedullary tumors, such as ependymomas and astrocytomas, and extramedullary tumors, such as neurofibromas and meningiomas, are the main tasks of this unit. Yearly, more than 400 cases of tumors undergo resection. Additionally, some craniocervical junction malformations, such as Chiari malformations, are treated surgically.

BRANCHES AND COLLABORATIVE CENTERS

BTHNC has created two clinical branches in Beijing and ten collaborating neurosurgery facilities around China. These facilities provide an opportunity for over 1000 patients annually to receive specialized care from Tiantan’s neurosurgery experts, all within the convenience and comfort of a local hospital. Furthermore, these outreach endeavors facilitate the progress of neurosurgical methodology in nearby medical facilities.

Facilities that provide direct support to the Neurosurgical Centers of Excellence

The operation rooms were reconstructed in 2003 and can accommodate 15 state-of-the-art units specifically designed for neurosurgery. The neurosurgical ICU is equipped with advanced technologies for crucial physiological monitoring and intensive brain monitoring procedures, such as transcranial Doppler and cerebral metabolic monitoring.

The Neuronavigation System and real-time ultrasound monitoring are used in conjunction with an open MRI machine. Intraoperative electrophysiological monitoring is a standard procedure used during skullbase, intramedullary, and epilepsy procedures. The intraoperative angiogram involves the use of both digital subtraction angiography (DSA) and indocyanine green (ICG) angiograms.

The neuroimaging facility is equipped with four sets of MRI machines, each with a strength of 3.0 telsa. Additionally, there are four sets of CT scanners, two sets of DSA machines, as well as ECT and Magnetic Encephalogram (MEG) units. PACS: Since 2002, the findings of all laboratory tests and imaging investigations conducted in the clinic have been accessible throughout the hospital via the intranet. Additionally, it facilitates the management and enhances the overall efficiency of all resources.

NEUROVASCULAR INTERVENTION UNIT

Most famous neurovascular intervention unit in China since its founding in the 1980s. Currently, about 1000 patients undergo interventional diagnosis and treatment each year. In addition to the embolization of aneurysms, vascular malformations and fistulas, it also uses stents for ischemic stroke.

RADIOTHERAPY CENTER

Gamma knife radiosurgery has been employed since 1994. In the past 5 years, more than 1000 patients have undergone GKR annually. It shows excellent tumor control in pituitary adenomas, acoustic neuromas, skull base meningiomas, and brain metastatic tumors. Conventional radiotherapy is also available at this center. Germinoma and medulloblastoma patients receive a combination of radiotherapy and chemotherapy.

RESEARCH CENTER: BEIJING NEUROSURGICAL INSTITUTE

Founded in 1960, includes research departments in microanatomy, neurotransmission, neuroendocrinology, neural injury and repair, neural stem cells, neurobiology, and cerebral vascular disease, as well as a state-certified lab animal center.

ACADEMIC COMMUNICATION

Yearly, many world-renowned neurosurgeons visit this institution, such as. Drs. Law, A. L. Rhoton, R. Spetzler, J. Ausman, Suzuki, V. Dolenc, Samii, A. Perneczky, Bason, Atos, etc. Annually, BTHNC hosts national conventions of neurosurgery and continuous training courses in microanatomy, surgical technique, new concepts of neurosurgery, etc. Hundreds of participants from all over China attend.

RESIDENCY AND FELLOWSHIP TRAINING

Yearly, about 20 residents and more than 100 neurosurgeons from all over China receive their training and fellowship at BTHNC.